XML 122 R69.htm IDEA: XBRL DOCUMENT v3.24.1
Capital Stock - Restricted Share Unit Activity (Details) - Restricted Share Units (RSUs) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 28, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Employee Service Share Based Compensation Tax Deficiencies Realized From Exercise Of Stock Options $ 0 $ 0 $ 0
Number of awards granted 8,097,408 11,882,500  
Allocated Share-based Compensation Expense $ 33 $ 34 $ 35
Number (000’s)      
Beginning balance 19,640,000    
Grants during the period, Number 8,097,000    
Vested during the period, Number (5,636,000)    
Cancelled during the period, Number (5,800,000)    
Ending balance 16,301,000 19,640,000  
Expected to Vest, Outstanding Number 13,491,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments other than Options, Weighted Average Grant Date Fair Value [Roll Forward]      
Beginning balance, Weighted-Average Grant Date Fair Value $ 5.92    
Granted during the period, Weighted Average Grant Date Fair Value 3.51 $ 4.29 $ 9.72
Vested during the period, Weighted-Average Grant Date Fair Value 6.76    
Cancelled during the period, Weighted-Average Grant Date Fair Value 6.31    
Ending balance, Weighted-Average Grant Date Fair Value 4.30 $ 5.92  
Expected to Vest, Weighted Average Grant Date Fair Value $ 4.29    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Average Remaining Contractual Life in Years 1 year 8 months 4 days    
Aggregate Intrinsic Value $ 45    
Vested and Expected to Vest, Average Remaining Contractual Life in Years 1 year 7 months 28 days    
Vested and Expected to Vest, Intrinsic Value $ 38    
Unrecognized compensation expense $ 53    
Weighted-average vesting period related to unrecognized share-based compensation on unvested awards 1 year 7 months 17 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 38 $ 40 $ 69